v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings
Balance, beginning of period, shares at Dec. 31, 2023   29,541,000        
Balance, beginning of period at Dec. 31, 2023 $ 273,326 $ 713 $ 490,947 $ (1,136,055) $ (50,413) $ 968,134
Net Income (Loss)           19,467
Foreign currency translation adjustments         (4,975)  
Total comprehensive income 14,492          
Repurchase of common stock, shares   (344,000)        
Repurchase of common stock (18,223) $ (2) (8,538) (9,683)    
Issuance of common stock pursuant to employee stock purchase plan 866   866      
Issuance of common stock pursuant to employee stock purchase plan, shares   20,000        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   573,000        
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 6 (6)      
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (11,000)        
Stock-based compensation expense 7,736   7,736      
Dividends (8,857)         (8,857)
Balance, ending of period, shares at Mar. 31, 2024   29,779,000        
Balance, ending of period at Mar. 31, 2024 269,340 $ 717 491,005 (1,145,738) (55,388) 978,744
Balance, beginning of period, shares at Dec. 31, 2023   29,541,000        
Balance, beginning of period at Dec. 31, 2023 273,326 $ 713 490,947 (1,136,055) (50,413) 968,134
Net Income (Loss) 33,296          
Foreign currency translation adjustments (5,216)          
Total comprehensive income 28,080          
Balance, ending of period, shares at Jun. 30, 2024   29,591,000        
Balance, ending of period at Jun. 30, 2024 273,329 $ 717 499,995 (1,155,542) (55,629) 983,788
Balance, beginning of period, shares at Mar. 31, 2024   29,779,000        
Balance, beginning of period at Mar. 31, 2024 269,340 $ 717 491,005 (1,145,738) (55,388) 978,744
Net Income (Loss) 13,829         13,829
Foreign currency translation adjustments (241)       (241)  
Total comprehensive income 13,588          
Repurchase of common stock, shares   (228,000)        
Repurchase of common stock (10,201)   (397) (9,804)    
Issuance of common stock pursuant to employee stock purchase plan 752   752      
Issuance of common stock pursuant to employee stock purchase plan, shares   20,000        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   90,000        
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 1 (1)      
Cancellation of restricted common stock issued pursuant to stock-based compensation plans   $ (1) 1      
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (70,000)        
Stock-based compensation expense 8,635   8,635      
Dividends (8,785)         (8,785)
Balance, ending of period, shares at Jun. 30, 2024   29,591,000        
Balance, ending of period at Jun. 30, 2024 $ 273,329 $ 717 499,995 (1,155,542) (55,629) 983,788
Balance, beginning of period, shares at Dec. 31, 2024 28,854,000 28,854,000        
Balance, beginning of period at Dec. 31, 2024 $ 282,569 $ 718 518,215 (1,194,224) (62,290) 1,020,150
Net Income (Loss)           16,130
Foreign currency translation adjustments         6,823  
Total comprehensive income 22,953          
Repurchase of common stock, shares   (358,000)        
Repurchase of common stock (22,236) $ (2) (12,807) (9,427)    
Issuance of common stock pursuant to employee stock purchase plan 769 $ 0 769 0    
Issuance of common stock pursuant to employee stock purchase plan, shares   15,000        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   608,000        
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 6 (6)      
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (15,000)        
Stock-based compensation expense 8,404   8,404      
Dividends (9,364)         (9,364)
Balance, ending of period, shares at Mar. 31, 2025   29,104,000        
Balance, ending of period at Mar. 31, 2025 $ 283,095 $ 722 514,575 (1,203,651) (55,467) 1,026,916
Balance, beginning of period, shares at Dec. 31, 2024 28,854,000 28,854,000        
Balance, beginning of period at Dec. 31, 2024 $ 282,569 $ 718 518,215 (1,194,224) (62,290) 1,020,150
Net Income (Loss) 28,397          
Foreign currency translation adjustments 20,398          
Total comprehensive income $ 48,795          
Balance, ending of period, shares at Jun. 30, 2025 28,877,000 28,877,000        
Balance, ending of period at Jun. 30, 2025 $ 290,721 $ 722 522,824 (1,220,897) (41,892) 1,029,964
Balance, beginning of period, shares at Mar. 31, 2025   29,104,000        
Balance, beginning of period at Mar. 31, 2025 283,095 $ 722 514,575 (1,203,651) (55,467) 1,026,916
Net Income (Loss) 12,267         12,267
Foreign currency translation adjustments 13,575       13,575  
Total comprehensive income 25,842          
Repurchase of common stock, shares   (289,000)        
Repurchase of common stock (18,222)   (976) (17,246)    
Issuance of common stock pursuant to employee stock purchase plan 676   676      
Issuance of common stock pursuant to employee stock purchase plan, shares   12,000        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   69,000        
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (19,000)        
Stock-based compensation expense 8,549   8,549      
Dividends $ (9,219)         (9,219)
Balance, ending of period, shares at Jun. 30, 2025 28,877,000 28,877,000        
Balance, ending of period at Jun. 30, 2025 $ 290,721 $ 722 $ 522,824 $ (1,220,897) $ (41,892) $ 1,029,964